Serine palmitoyltransferase inhibitor myriocin induces growth inhibition of B16F10 melanoma cells through G(2) /M phase arrest. [electronic resource]
Producer: 20110905Description: 320-9 p. digitalISSN:- 1365-2184
- Animals
- Antineoplastic Agents -- pharmacology
- CDC2 Protein Kinase -- biosynthesis
- Cell Cycle -- drug effects
- Cell Line, Tumor
- Cell Proliferation -- drug effects
- Ceramides -- biosynthesis
- Cyclin B1 -- biosynthesis
- Fatty Acids, Monounsaturated -- pharmacology
- Gene Expression Regulation, Neoplastic -- drug effects
- Lysophospholipids -- biosynthesis
- Melanoma, Experimental -- drug therapy
- Mice
- Proto-Oncogene Proteins p21(ras) -- biosynthesis
- Serine C-Palmitoyltransferase -- antagonists & inhibitors
- Skin Neoplasms -- drug therapy
- Sphingomyelins -- biosynthesis
- Sphingosine -- analogs & derivatives
- Tumor Suppressor Protein p53 -- biosynthesis
- cdc25 Phosphatases -- biosynthesis
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.